Substrate
world

Study Estimates Long COVID Economic Burden Above $8 Billion Through 2027

A computational model projects annual U.S. costs between $2 billion and $3.4 billion depending on incidence rates. Productivity losses account for more than 90 percent of the total.

FO
1 source·May 26, 9:00 PM(2 days ago)·1m read
Study Estimates Long COVID Economic Burden Above $8 Billion Through 2027rediff.com
Audio version
Tap play to generate a narrated version.

A study published in 2025 in the Journal of Infectious Diseases estimated that the total economic burden of long COVID in the United States will likely exceed $8 billion between 2025 and the end of 2027. The model calculated that a single case of long COVID costs between $9,906 and $11,646 per year on average. Productivity losses represent more than 90 percent of these costs.

Researchers used incidence rates between 6 percent and 20 percent of COVID-19 cases. 01 billion. 4 billion. Extending symptom duration to three years at the 6 percent incidence rate produced the $8 billion total for 2025-2027. The authors noted that many individuals who developed long COVID five to six years earlier continue to report symptoms.

The study stated there is currently no cure and treatment focuses on symptom management. It also reported a shortage of specialized long COVID clinics. In 2025 the Department of Health and Human Services closed the Office of Long COVID Research. The National Institutes of Health ended several related funding initiatives the same year.

The authors concluded that without changes in prevention or treatment resources, both the number of cases and associated costs are expected to increase.

Key Facts

$8 billion
projected total U.S. economic burden 2025-2027
$9,906-$11,646
average annual cost per long COVID case
Over 90%
share of costs attributed to lost productivity
6%-20%
range of COVID-19 cases developing long COVID

Potential Impact

  1. 01

    Employers face continued productivity losses from workers with persistent symptoms.

  2. 02

    Reduced federal research funding may limit new treatment development options.

  3. 03

    Existing long COVID clinics may see increased demand without added capacity.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count207 words
PublishedMay 26, 2026, 9:00 PM
Bias signals removed2 across 1 outlet
Signal Breakdown
Amplifying 1Editorializing 1

Related Stories

WHO Chief Visits DRC as Ebola Death Rate Reaches 30-50%The Guardian
world29 min ago

WHO Chief Visits DRC as Ebola Death Rate Reaches 30-50%

World Health Organization director-general Tedros Adhanom Ghebreyesus arrived in the Democratic Republic of the Congo to support containment of a new Ebola outbreak. The agency revised the death rate to 30-50% based on confirmed cases and recorded 10 confirmed and 223 suspected d…

SK
The Guardian
2 sources
Greek National Charged in UK With Aiding Iran-Linked Intelligence Servicewesternjournal.com
world29 min ago

Greek National Charged in UK With Aiding Iran-Linked Intelligence Service

A 46-year-old Greek man living in Germany was charged under the UK National Security Act with assisting an intelligence service believed to be Iran by targeting a journalist at Iran International.

Reuters
BBC News
2 sources
Journalists in Gaza to Receive 2026 Golden Pen of Freedom Awardstraitstimes.com
world2 hrs ago

Journalists in Gaza to Receive 2026 Golden Pen of Freedom Award

Three international news agencies will accept the award on behalf of their local staff still reporting from the territory. The World Association of News Publishers cited the journalists' continued coverage under extreme conditions.

Al-Monitor
AF
2 sources